BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-1.13%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.86B
AUM Growth
+$4.04B
(+222%)
Cap. Flow
+$4.03B
Cap. Flow
% of AUM
68.76%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
219
New
83
Increased
86
Reduced
22
Closed
16
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$492M |
| 2 |
Incyte
INCY
|
$310M |
| 3 |
Neurocrine Biosciences
NBIX
|
$298M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$239M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$239M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$29.2M |
| 2 |
Cencora
COR
|
$19.9M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$16.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$14.7M |
| 5 |
Illumina
ILMN
|
$10.9M |
Sector Composition
| 1 | Healthcare | 94.72% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.42% |
| 4 | Financials | 0.06% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
126
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.22M | 0.04% |
21,500
+7,000
| +48% | +$721K |
|
127
uniQure
QURE
$973M
| $2.16M | 0.04% |
27,600
-10,700
| -28% | -$836K |
|
|
GWPH
128
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.13M | 0.04% |
12,353
| – | – |
|
129
Ascendis Pharma
ASND
$12B
| $2.1M | 0.04% |
18,200
| – | – |
|
|
CTLT
130
DELISTED
CATALENT, INC.
CTLT
| $2.03M | 0.03% |
+37,500
| New | +$2.03M |
|
131
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$60.5M
| $2.02M | 0.03% |
5,600
+1,850
| +49% | +$667K |
|
132
Amicus Therapeutics
FOLD
$2.47B
| $1.87M | 0.03% |
150,000
| – | – |
|
133
Pfizer
PFE
$140B
| $1.73M | 0.03% |
42,160
| – | – |
|
134
Regenxbio
RGNX
$498M
| $1.7M | 0.03% |
33,100
| – | – |
|
|
MDCO
135
DELISTED
Medicines Co
MDCO
| $1.59M | 0.03% |
43,500
+14,500
| +50% | +$529K |
|
|
BPMC
136
DELISTED
Blueprint Medicines
BPMC
| $1.46M | 0.03% |
+15,500
| New | +$1.46M |
|
137
Ultragenyx Pharmaceutical
RARE
$3.01B
| $1.45M | 0.02% |
22,800
-7,000
| -23% | -$445K |
|
|
WCG
138
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.38M | 0.02% |
4,851
-102,568
| -95% | -$29.2M |
|
139
Fate Therapeutics
FATE
$112M
| $1.2M | 0.02% |
+59,000
| New | +$1.2M |
|
140
Labcorp
LH
$22.9B
| $1M | 0.02% |
6,731
-73
| -1% | -$10.8K |
|
141
AnaptysBio
ANAB
$590M
| $959K | 0.02% |
+17,000
| New | +$959K |
|
142
McKesson
MCK
$86B
| $826K | 0.01% |
6,149
-37
| -0.6% | -$4.97K |
|
143
Viking Therapeutics
VKTX
$2.98B
| $797K | 0.01% |
+96,000
| New | +$797K |
|
|
AUTL
144
Autolus Therapeutics
AUTL
$386M
| $547K | 0.01% |
+34,000
| New | +$547K |
|
145
Mercado Libre
MELI
$123B
| $511K | 0.01% |
+835
| New | +$511K |
|
|
AFMD
146
DELISTED
Affimed
AFMD
| $481K | 0.01% |
16,750
| – | – |
|
147
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.39M
| $426K | 0.01% |
+6,250
| New | +$426K |
|
148
MSCI
MSCI
$43.1B
| $426K | 0.01% |
+1,786
| New | +$426K |
|
149
MarketAxess Holdings
MKTX
$6.73B
| $425K | 0.01% |
+1,322
| New | +$425K |
|
150
Estee Lauder
EL
$31.5B
| $412K | 0.01% |
+2,248
| New | +$412K |
|